Mon, August 7, 2023

Gregory Fraser Maintained (AMRX) at Strong Buy with Increased Target to $6 on, Aug 7th, 2023

Gregory Fraser of Truist Securities, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Strong Buy with Increased Target from $4 to $6 on, Aug 7th, 2023.

Gregory, nor any peers, have made any analyst calls on AMRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30